Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | CPTN | Employee Stock Option (right to buy) | Apr 5, 2022 | Common Stock | 612K | $1.26 | Direct | F1, F2 | ||||||
holding | CPTN | Warrants (right to buy) | Apr 5, 2022 | Common Stock | 12.5K | $11.50 | Direct | F3 |
Id | Content |
---|---|
F1 | The stock options vested as to 25% of the total number of shares of Common Stock subject to the stock options on January 19, 2022. The remaining 75% of the total number of shares of Common Stock subject to the stock options vest thereafter in 36 substantially equal monthly installments. |
F2 | Pursuant to the Business Combination Agreement, dated as of August 4, 2021 (as amended by the Amendment to the Business Combination Agreement, dated as of January 21, 2022), by and among Growth Capital Acquisition Corp. ("GCAC" and, upon consummation of the business combination, the surviving issuer as renamed Cepton, Inc.), Cepton Technologies, Inc., a Delaware corporation ("Former Cepton"), and GCAC Merger Sub Inc., a Delaware corporation and a direct, wholly owned subsidiary of GCAC, on February 10, 2022, all shares of stock subject to stock options of Former Cepton were automatically converted into shares of the Issuer's Common Stock based on a 1-to-2.449 conversion ratio. |
F3 | Subject to the terms of the warrant agreement relating thereto, the warrants become eligible for exercise following the effectiveness of the Issuer's registration statement on Form S-1 (File No. 333-262668), initially filed with the SEC on February 11, 2022. |